(Date:7/24/2008)... The Palomino Group, a le... organization, today announced the launch of its n... to the biopharmaceutical industry. The company, b...ursement and commercialization consulting services...al device, and other healthcare companies. , ...
(Date:7/23/2008)... Output of New Molecular Entities Drops to Histori... Competition from Generics Companies, LONDON, Jul...omson,Reuters today announced the availability of ...eutical R&D Factbook, an indispensable reference,a...harmaceutical R&D,corporate finance, business str...
(Date:7/23/2008)... IVF clinic expands welcome to out-of-state...Newswire/ -- The recent California,Supreme Court d...the,commitment of the Reproductive Science Center ...fertility practices, to serving gays and lesbians ...ation of same-sex marriage supports RSC,s,long-hel...
(Date:7/23/2008)... Full line of vaccines for Immigration and Natural... Health, BALTIMORE, July 23 /PRNewswire/ -...is applying for an immigrant visa for entry into t...r permanent residence. Applicants,must show proof ...es, as,recommended by the U.S. Advisory Committee ...
Breaking Medicine News(10 mins):Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 2Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 3Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:USCIS Tightens Vaccination Requirements 2(Date:7/23/2008)...ATTLE, July 23 /- Sound Pharmaceutica...lication with the FDA for the clinical,testing of ...ntion of,chemotherapy induced hearing loss or otot...3005, will be tested in advanced stage lung cancer...num based chemotherapy.,This marks the second deve...
(Date:7/23/2008)...ATTLE, July 23 /- Dendreon ...it expects the Independent Data,Monitoring Committ...alysis,of overall survival relating to the Company...oCarcinoma Treatment, also known as D9902B) clinic...s the Company,s investigational,active cellular im...
(Date:7/22/2008)...test awards under Therapeutics Development Initiat...tions to 23; next deadline January 20,2009, NEW ...f its mission to,speed delivery of transformative ... Michael J. Fox Foundation for Parkinson,s Researc... industry research teams. The awards,were granted ...
(Date:7/22/2008)... Geoffrey Allan Will Stress the Importance to Pati...gics Approval Pathway, RICHMOND, Va., July 22 /PR...M) a developer of follow-on biologics and biopharm...h.D., CEO of Insmed, will present at a,Congression...the,significant need for establishing an approval ...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Titanium Group to Attend Regional ICT Meeting in Thailand 3031 1Titanium Group to Attend Regional ICT Meeting in Thailand 3031 2Titanium Group to Attend Regional ICT Meeting in Thailand 3031 3Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 4823 1Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 4823 2Former Bristol Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood Thinning Drug 17600 1Former Bristol Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood Thinning Drug 17600 2Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 1Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 2Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 3Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 4Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 5Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 6Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 7Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 8Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 9Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 10... Data Also Show Nebivolol Lowers Blood Pressure in...O, May 21, 2007 /PRNewswire-FirstCall/ -- Forest,L...om two clinical,studies and one pooled analysis of...lating properties currently under review by,the U....tment of,hypertension. Data from the two clinical ...
... - Data being presented today at Digestive Disease...e/ -- Microbia today,announced the presentation of...celerated colonic transit and improved bowel funct...itable bowel syndrome,(IBS-C). These data also sho...dence of adverse events. Linaclotide is a first-in...
Other Medicine Technology:Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings.
...tion to securely access patient information, image...rs can login from virtually anywhere with a secure...udies. , Secure web-based access to patient i...sired patient study with searchable fields, Supp...
Instra-Glide Target is the non-silicone lubricant designed to "spot" lubricate moving parts , ,Instra-Glide Target lubricates sticky pivot points, hinges, box joints and other moving parts. The pen
Shandon Excelsior ES Tissue Processor continues the Thermo Electron Corporation tradition of offering one of the most advanced, traditional reagent instruments available today.
Medicine Products: